On 6 May 2025, the Beneluxa Initiative organised a meeting that brought together representatives from the Belgian and Dutch advisory bodies on medicines reimbursement: the CRM (Commission for the Reimbursement of Medicines, Belgium), WAR (Scientific Advisory Board, Netherlands)...
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
From Assessment to Appraisal: Beneluxa Initiative hosts meeting with Advisory Bodies on Medicines Reimbursement
Steering Committee Meeting in Vienna, Austria
Today, the Steering Committee of the Beneluxa Initiative convened in Vienna, Austria, for its bi-annual meeting, bringing together representatives from member countries to discuss progress, priorities, and future strategy. The agenda covered a range of key topics, including...
The Beneluxa iniative identified thirteen impactful medicines suitable for joint HTA submission
Starting from more than 200 medicines in the pipeline (status January 2024) mentioned in The High Impact Reports of the International Horizon Scan Initiative, a selection of impactful medicines was made. Criteria such as new chemical entity and potential game changer in clinical...